MilliporeSigma
  • Home
  • Search Results
  • Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.

Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.

PloS one (2015-01-31)
Ana C A X De-Oliveira, Kátia S Poça, Paulo R R Totino, Francisco J R Paumgartten
ABSTRACT

Mouse cytochrome P450 (CYP) 2A5 is induced by inflammatory conditions and infectious diseases that down-regulate the expression and activity of most other CYP isoforms. Enhanced oxidative stress and nuclear factor (erythroid 2-related factor) 2 (Nrf2) transcription factor activation have been hypothesised to mediate up-regulation of CYP2A5 expression in the murine liver. The unique and complex regulation of CYP2A5, however, is far from being thoroughly elucidated. Sepsis and high doses of bacterial lipopolysaccharide (LPS) elicit oxidative stress in the liver, but depression, not induction, of CYP2A5 has been observed in studies of mice treated with LPS. The foregoing facts prompted us to evaluate the response of CYP2A5 liver activity in female DBA-2 mice over a broad range of LPS doses (0, 0.025, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, and 20 mg/kg). Cytokine levels (interleukin [IL]-2, IL-4, IL-6, IL-10, IL-17A, interferon gamma, tumour necrosis factor alpha) and nitric oxide (NO) were measured in the blood serum. Activities of CYP1A (EROD) and CYP2B (BROD) in the liver were also determined for comparative purposes. LPS depressed CYP2A5 at low doses (0.025-2.0 mg/kg) but not at doses (>2 mg/kg) that increased pro-inflammatory cytokines and NO serum levels, and depressed CYP1A and CYP2B activities. Blockade of pro-inflammatory cytokines and the overproduction of NO induced by co-treatment with pentoxifylline and LPS and iNOS inhibition with aminoguanidine both extended down-regulation of CYP2A5 to the high dose range while not affecting LPS-induced depression of CYP1A and CYP2B. Overall, the results suggested that NO plays a role in the reversal of the low-dose LPS-induced depression of CYP2A5 observed when mice were challenged with higher doses of LPS.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Coumarin, ≥99% (HPLC)
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide phosphate sodium salt hydrate
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide 2′-phosphate reduced tetrasodium salt hydrate, ≥93% (HPLC)
Sigma-Aldrich
Sodium nitrate, 99.995% trace metals basis
Sigma-Aldrich
Resorufin ethyl ether
Sigma-Aldrich
Resorufin benzyl ether, CYP450 substrate
Sigma-Aldrich
Glucose-6-phosphate Dehydrogenase from baker's yeast (S. cerevisiae), Type XV, lyophilized powder, 200-400 units/mg protein (modified Warburg-Christian)
Sigma-Aldrich
N-(1-Naphthyl)ethylenediamine dihydrochloride, ≥98%
Sigma-Aldrich
Sulfanilamide, puriss. p.a., ≥99% (calc. to the dried substance)
Sigma-Aldrich
Sodium nitrate, BioUltra, ≥99.0% (T)
Supelco
Sulfanilamide, VETRANAL®, analytical standard
Sigma-Aldrich
Resorufin ethyl ether, suitable for fluorescence, ≥95% (UV)
Sigma-Aldrich
Sulfanilamide, ≥98%
Sigma-Aldrich
D-Glucose 6-phosphate disodium salt hydrate, ≥98%
Sigma-Aldrich
Sodium nitrate, ≥99.0%, suitable for plant cell culture
Sigma-Aldrich
Sodium nitrate, BioXtra, ≥99.0%
Supelco
Sulfanilamide melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
Coumarin, primary reference standard
Sigma-Aldrich
Sodium nitrate-14N, 99.95 atom % 14N
USP
Sulfanilamide Melting Point Standard, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Coumarin, ≥98%
Supelco
Coumarin, certified reference material, TraceCERT®
Supelco
Sodium nitrate, analytical standard
Sigma-Aldrich
Sodium nitrate, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Sodium nitrate, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%
Coumarin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Sodium nitrate, ACS reagent, ≥99.0%
Sulfanilamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Resorufin, 95%
USP
Sulfanilamide, United States Pharmacopeia (USP) Reference Standard